Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PSD | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | DDX21 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | ZNF445 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | CKS1B | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | TOP2B | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | HR | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | ZNF784 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | IDH2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | MSANTD3-TMEFF1 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-06 |
mRNA | CHRNB2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |